52 查找结果 for "innovation" 清空筛选
In the 2025 financial year, Datwyler generated revenue of CHF 1'100.5 million. Adjusted for negative currency effects of -3.7%, the company achieved organic growth of 3.1%. Due to these currency effects, reported revenue was overall 0.6% below the prior-year level.
Datwyler announced a collaboration with LTS Device Technologies, a developer of smart wearable devices for drug delivery, and Stevanato Group
Datwyler has signed an agreement to acquire 51% of Capsul’Invest SA und Brain Corp SA (together operating as Capsul’in), a leading provider of aluminum coffee capsule solutions headquartered in Luxembourg with annual revenues of approximately EUR 90 million.
Wearables have become a major driver of innovation in personalized healthcare in recent years. Learn more about how we turn insights into solutions through our solution design approach on the example of SoftPulse(sup:TM) Flex
德特威勒通过启动GLP-1注射疗法高端包装组件的批量供应，进一步巩固其市场地位并推动增长。这体现了其在快速扩张的注射剂市场中所做的战略投资及早期开发合作伙伴关系。
Datwyler's specialized sealing solutions ensure the efficient and reliable operation of electrolyzers and auxiliary systems.
Datwyler slightly increased its EBIT margin in 2024 despite weak markets and a slight decline in revenue. The transformation program «ForwardNow» will accelerate the planned profitable growth.
Datwyler is launching a transformation program for the period 2025 to 2027 to accelerate revenue and profitability growth.
电芯密封会影响电池的机械稳定性和热管理性能，它对于在各种工况条件下电池保持最佳性能至关重要。
德特威勒推出 NeoFlex™ 活塞，适用于大容量生物制剂的自动注射器和可穿戴式注射器。
随着世界向可持续能源系统的转型，绿色氢能正迅速成为未来能源战略的基石。
Volker Cwielong于2024年4月1日正式接任德特威勒首席执行官。同时，自2017年以来一直担任该职位的Dirk Lambrecht于2024年3月底正式卸任，并于2024年3约14
Momentive、Datwyler 和 BSC Computer 将开展深度合作并向工业市场推出了介电弹性体执行器（DEA）创新解决方案。
德特威勒签约英国经销商Conserva UK，在英国市场建立更优化的药品初级包装供应链。该战略联盟旨在通过利用 Conserva UK 作为其尊贵客户群的主要联络点，增强德特威勒在英国的影响力。
德特威勒已经将业务能力范围扩大到了氢燃料电池技术的应用领域，助力客户向氢燃料电池技术转型。
